Hepatocellular carcinoma (HCC) is the most frequent primary liver malignancy and the third
cause of cancer-related death in the Western Countries. The well-established causes of …

The Liver Imaging Reporting and Data System (LI-RADS) standardizes the interpretation,
reporting, and data collection for imaging examinations in patients at risk for hepatocellular …

Purpose To perform a systematic review and meta-analysis of the diagnostic performance of
computed tomography (CT) and magnetic resonance (MR) imaging as noninvasive …

Like the investigators from Barcelona [1] we also observed the occurrence of hepatocellular
carcinoma (HCC) in patients with advanced liver disease shortly after interferon (IFN)-free …

Purpose To compare the per-lesion sensitivity and positive predictive value (PPV) of
ultrasonography (US), computed tomography (CT), and magnetic resonance imaging (MRI) …

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and a major
public health problem worldwide. Hepatocarcinogenesis is a complex multistep process at …

Hepatocellular carcinoma (HCC) is the most common primary liver neoplasm and one of the
most common causes of death in patients with cirrhosis of the liver. In parallel with …

Purpose The purpose of this study was to evaluate the diagnostic performance of a
“simulated” abbreviated MRI (AMRI) protocol using diffusion-weighted imaging (DWI) and T1 …

Objectives The primary objective was to compare the performance of 3 different abbreviated
MRI (AMRI) sets extracted from a complete gadoxetate-enhanced MRI obtained for …

Objectives To evaluate the diagnostic performance of contrast-enhanced CT vs. MRI with
extracellular contrast agents (EC-MRI) vs. MRI with gadoxetic acid (EOB-MRI) for HCC …